Tae Kim and Max Nisen

Even Covid Can’t Justify $18.5 Billion Telehealth Deal

Not all deals are worth the risk. And yet, many management teams can’t resist the temptation to try building larger empires through big, pricey acquisitions — even ones that might lead them off track. This appears to be the case with the latest proposed merger between two leading digital-health…